CD47 update: A multifaceted actor in the tumour microenvironment of potential therapeutic interest

British Journal of Pharmacology

Volumn 167, Issue 7, 2012, Pages 1415-1430

  Sick, E ^a,b   Jeanne, A ^a   Schneider, C ^a   Dedieu, S ^a   Takeda, K ^b   Martiny, L ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

angiogenesis; apoptosis; immunity; inflammation; integrin associated protein; migration; proliferation

Indexed keywords

ALPHA2BBETA3 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; ALPHAMBETA2 INTEGRIN; ANTINEOPLASTIC AGENT; CD36 ANTIGEN; CD47 ANTIGEN; CD47 MONOCLONAL ANTIBODY; CYCLIC AMP DEPENDENT PROTEIN KINASE; ERYTHROCYTE BAND 4.2 PROTEIN; FAS ANTIGEN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BNIP3; PROTEIN CDC42; PROTEIN KINASE SYK; RAC PROTEIN; RITUXIMAB; SERINE PROTEINASE INHIBITOR; SERPIN A1; STEROID RECEPTOR COACTIVATOR; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 4; VITRONECTIN RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; STROMA CELL; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD47; HUMANS; NEOPLASMS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84868660422     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02099.x     Document Type: Review

References (147)

1. Adams JC, (2001). Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 17: 25-51.
2. Avice MN, Rubio M, Sergerie M, Delespesse G, Sarfati M, (2001). Role of CD47 in the induction of human naïve T cell anergy. J Immunol 167: 2459-2468.
3. Babic I, Schallhorn A, Lindberg FP, Jirik FR, (2000). SHPS-1 induces aggregation of Ba/F3 pro-B cells via interaction with CD47. J Immunol 164: 3652-3658.
4. Balkwill F, Mantovani A, (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
5. Bamberger ME, Harris ME, McDonald DR, Husemann J, Landreth GE, (2003). A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation. J Neurosci 23: 2665-2674.
6. Barazi HO, Li Z, Cashel JA, Krutzsch HC, Annis DS, Mosher DF, et al,. (2002). Regulation of integrin function by CD47 ligands. J Biol Chem 277: 42859-42866.
7. Barbier S, Chatre L, Bras M, Sancho P, Roué G, Virely C, et al,. (2009). Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton. Haematologica 94: 507-517.
8. Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, Pagano PJ, et al,. (2010). Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res 88: 471-481.
9. Bergers G, Hanahan D, (2008). Modes of resistance to anti-angiogenic therapy. Nature Rev Cancer 8: 592-603.
10. Bras M, Yuste VJ, Roué G, Barbier S, Sancho P, Virely C, et al,. (2007). Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol Cell Biol 27: 7073-7088.
11. Brittain JE, Han J, Ataga KI, Orringer EP, Parise LV, (2004). Mechanism of CD47-induced α4β1 integrin activation and adhesion in sickle reticulocytes. J Biol Chem 279: 42393-42402.
12. Brooke G, Holbrook JD, Brown MH, Barclay AN, (2004). Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J Immunol 173: 2562-2570.
13. Brooke GP, Parsons KR, Howard CJ, (1998). Cloning of two members of the SIRPα family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur J Immunol 28: 1-11.
14. Broom OJ, Zhang Y, Oldenborg PA, Massoumi R, Sjölander A, (2009). CD47 regulates collagen I-induced cyclooxygenase-2 expression and intestinal epithelial cell migration. PLoS ONE 4: e6371.
15. Brown E, Hooper L, Ho T, Gresham H, (1990). Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 111: 2785-2794.
16. Brown EJ, Frazier WA, (2001). Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 11: 130-135.
17. Bruce LJ, Ghosh S, King MJ, Layton DM, Mawby WJ, Stewart GW, et al,. (2002). Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex. Blood 100: 1878-1885.
18. Campbell IG, Freemont PS, Foulkes W, Trowsdale J, (1992). An ovarian tumour marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 52: 5416-5420.
19. Capo C, Lindberg FP, Meconi S, Zaffran Y, Tardei G, Brown EJ, et al,. (1999). Subversion of monocyte functions by Coxiella burnetii: impairment of the cross-talk between avb3 integrin and CR3. J Immunol 163: 6078-6085.
20. Carmeliet P, Jain RK, (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473: 298-307.
21. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, et al,. (2000). A spontaneous murine melanoma lung metastasis comprised of host x tumour hybrids. Cancer Res 60: 2512-2519.
22. Chames P, Van Regenmortel M, Weiss E, Baty D, (2009). Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 157: 220-233.
23. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, et al,. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumour-initiating cells. Proc Natl Acad Sci USA 106: 14016-14021.
24. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, et al,. (2010a). Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142: 699-713.
25. Chao MP, Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, Gentles AJ, Volkmer J, et al,. (2010b). Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2: 63ra94.
26. Chao MP, Alizadeh AA, Tang C, Jan M, Weissman-Tsukamoto R, Zhao F, et al,. (2011). Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukaemia. Cancer Res 71: 1374-1384.
27. Chung J, Gao AG, Frazier WA, (1997). Thrombospondin acts via integrin-associated protein to activate the platelet integrin aIIb b3. J Biol Chem 272: 14740-14746.
28. Congote LF, Temmel N, (2004). The C-terminal 26-residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: role of protein kinase C and CD47. FEBS Lett 576: 343-347.
29. Cooper D, Lindberg FP, Gamble JR, Brown EJ, Vadas MA, (1995). Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci USA 92: 3978-3982.
30. Demeure CE, Tanaka H, Mateo V, Rubio M, Delespesse G, Sarfati M, (2000). CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J Immunol 164: 2193-2199.
31. de Vries HE, Hendriks JJ, Honing H, De Lavalette CR, van der Pol SM, Hooijberg E, et al,. (2002). Signal-regulatory protein a-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J Immunol 168: 5832-5839.
32. Dorahy DJ, Thorne RF, Fecondo JV, Burns GF, (1997). Stimulation of platelet activation and aggregation by carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor. J Biol Chem 272: 1323-1330.
33. Dunn GP, Old LJ, Schreiber RD, (2004). The three Es of cancer immunoediting. Annu Rev Immunol 22: 329-360.
34. Elkord E, Alcantar-Orozco EM, Dovedi SJ, Tran DQ, Hawkins RE, Gilham DE, (2010). T regulatory cells in cancer: recent advances and therapeutic potential. Expert Opin Biol Ther 10: 1573-1586.
35. Floquet N, Dedieu S, Martiny L, Dauchez M, Perahia D, (2008). Human thrombospondin's (TSP-1) C-terminal domain opens to interact with the CD47 receptor: a molecular modeling study. Arch Biochem Biophys 478: 103-109.
36. Frazier WA, Gao AG, Dimitry J, Chung J, Brown EJ, Lindberg FP, et al,. (1999). The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 274: 8554-8560.
37. Frazier WA, Isenberg JS, Kaur S, Roberts DD, (2010). CD47. Nature Signalling Gateway. doi: 10.1038/mp.a002870.01 Available at: http://www.signaling-gateway.org/molecule/query?afcsid=A002870 (accessed 19 September 2012).
38. Gao AG, Frazier WA, (1994). Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins. J Biol Chem 269: 29650-29657.
39. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA, (1996a). Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271: 21-24.
40. Gao AG, Lindberg FP, Dimitry JM, Brown EJ, Frazier WA, (1996b). Thrombospondin modulates avb3 function through integrin-associated protein. J Cell Biol 135: 533-544.
41. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeld A, Murphy-Ullrich JE, et al,. (2005). Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321-334.
42. Green JM, Zhelesnyak A, Chung J, Lindberg FP, Sarfati M, Frazier WA, et al,. (1999). Role of cholesterol in formation and function of a signalling complex involving αvβ3, integrin-associated protein (CD47), and heterotrimeric G proteins. J Cell Biol 146: 673-682.
43. Grimbert P, Bouguermouh S, Baba N, Nakajima T, Allakhverdi Z, Braun D, et al,. (2006). Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation. J Immunol 177: 3534-3541.
44. Han X, Sterling H, Chen Y, Saginario C, Brown EJ, Frazier WA, et al,. (2000). CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 275: 37984-37992.
45. Hanahan D, Weinberg RA, (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
46. Hatherley D, Graham SC, Turner J, Harlos K, Stuart DI, Barclay AN, (2008). Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell 31: 266-277.
47. Hatherley D, Graham SC, Harlos K, Stuart DI, Barclay AN, (2009). Structure of signal-regulatory protein α: a link to antigen receptor evolution. J Biol Chem 284: 26613-26619.
48. Hawighorst T, Velasco P, Streit M, Hong YK, Kyriakides TR, Brown LF, et al,. (2001). Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumour defence mechanism. EMBO J 20: 2631-2640.
49. Hermann P, Armant M, Brown E, Rubio M, Ishihara H, Ulrich D, et al,. (1999). The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 144: 767-775.
50. Hofman P, Piche M, Far DF, Le Negrate G, Selva E, Landraud L, et al,. (2000). Increased Escherichia coli phagocytosis in neutrophils that have transmigrated across a cultured intestinal epithelium. Infect Immun 68: 449-455.
51. Holledge MM, Millward-Sadler SJ, Nuki G, Salter DM, (2008). Mechanical regulation of proteoglycan synthesis in normal and osteoarthritic human articular chondrocytes: roles for α5 and αvβ5 integrins. Biorheology 45: 275-288.
52. Ichigotani Y, Matsuda S, Machida K, Oshima K, Iwamoto T, Yamaki K, et al,. (2000). Molecular cloning of a novel human gene (SIRP-B2) which encodes a new member of the SIRP/SHPS-1 protein family. J Hum Genet 45: 378-382.
53. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD, (2006). CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281: 26069-26080.
54. Isenberg JS, Romeo MJ, Abu-Asab M, Tsokos M, Oldenborg A, Pappan L, et al,. (2007). Increasing survival of ischemic tissue by targeting CD47. Circ Res 100: 712-720.
55. Isenberg JS, Romeo MJ, Yu C, Yu CK, Nghiem K, Monsale J, et al,. (2008a). Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signalling. Blood 111: 613-623.
56. Isenberg JS, Maxhimer JB, Hyodo F, Pendrak ML, Ridnour LA, DeGraff WG, et al,. (2008b). Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. Am J Pathol 173: 1100-1112.
57. Isenberg JS, Pappan LK, Romeo MJ, Abu-Asab M, Tsokos M, Wink DA, et al,. (2008c). Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg 247: 180-190.
58. Isenberg JS, Romeo MJ, Maxhimer JB, Smedley J, Frazier WA, Roberts DD, (2008d). Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. Ann Surg 247: 860-868.
59. Isenberg JS, Maxhimer JB, Pwers P, Tsokos M, Frazier WA, Roberts DD, (2008e). Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signalling. Surgery 144: 752-761.
60. Isenberg JS, Hyodo F, Ridnour LA, Shannon CS, Wink DA, Krishna MC, et al,. (2008f). Thrombospondin-1 and vasoactive agents indirectly alter tumour blood flow. Neoplasia 10: 886-896.
61. Isenberg JS, Shiva S, Gladwin M, (2009). Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation. Nitric Oxide 21: 52-62.
62. Ishii M, Iwai K, Koike M, Ohshima S, Kudo-Tanaka E, Ishii T, et al,. (2006). RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J Bone Miner Res 21: 965-976.
63. Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, et al,. (2009). CD47 is upregulated on circulating hematopoietic stem cells and leukaemia cells to avoid phagocytosis. Cell 138: 271-285.
64. Jiang P, Lagenaur CF, Narayanan V, (1999). Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem 274: 559-562.
65. Johansson U, Londei M, (2004). Ligation of CD47 during monocyte differentiation into dendritic cells results in reduced capacity for interleukin-12 production. Scand J Immunol 59: 50-57.
66. Kaur S, Martin-Manso G, Pendrak ML, Garfield SH, Isenberg JS, Roberts DD, (2010). Thrombospondin-1 inhibits VEFG receptor-2 signalling by disrupting its association with CD47. J Biol Chem 285: 38923-38932.
67. Kaur S, Kuznetsova SA, Pendrak ML, Sipes JM, Romeo MJ, Li Z, et al,. (2011). Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signalling by thrombospondin-1. J Biol Chem 286: 14991-15002.
68. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A, (1997). A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386: 181-186.
69. Kikuchi Y, Uno S, Yoshimura Y, Otabe K, Iida S, Oheda M, et al,. (2004). A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells. Biochem Biophys Res Commun 315: 912-918.
70. Kikuchi Y, Uno S, Kinoshita Y, Yoshimura Y, Iida S, Wakahara Y, et al,. (2005). Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumour potency for multiple myeloma. Leuk Res 29: 445-450.
71. Kim MJ, Lee JC, Lee JJ, Kim S, Lee SG, Park SW, et al,. (2008). Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines. Tumour Biol 29: 28-34.
72. Koenigsknecht J, Landreth G, (2004). Microglial phagocytosis of fibrillar β-amyloid through a β1 integrin-dependent mechanism. J Neurosci 24: 9838-9846.
73. Lamy L, Ticchioni M, Rouquette-Jazdanian AK, Samson M, Deckert M, Greenberg AH, et al,. (2003). CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis. J Biol Chem 278: 23915-23921.
74. Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A, (2007). Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 178: 5930-5939.
75. Lee EH, Hsieh YP, Yang CL, Tsai KJ, Liu CH, (2000). Induction of integrin-associated protein (IAP) mRNA expression during memory consolidation in rat hippocampus. Eur J Neurosci 12: 1105-1112.
76. Li SS, Forslöw A, Sundqvist KG, (2005). Autocrine regulation of T cell motility by calreticulin-thrombospondin-1 interaction. J Immunol 174: 654-661.
77. Li Z, He L, Wilson KE, Roberts DD, (2001). Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J Immunol 166: 2427-2436.
78. Lih CJ, Wei W, Cohen SN, (2006). Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes. Genes Dev 20: 2082-2095.
79. Lindberg FP, Gresham HD, Schwarz E, Brown EJ, (1993). Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in αvβ3-dependent ligand binding. J Cell Biol 123: 485-496.
80. Lindberg FP, Gresham HD, Reinhold MI, Brown EJ, (1996). Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J Cell Biol 134: 1313-1322.
81. Liu Y, Merlin D, Burst SL, Pochet M, Madara JL, Parkos CA, (2001). The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. J Biol Chem 276: 40156-40166.
82. Liu Y, Bühring HJ, Zen K, Burst SL, Schnell FJ, Williams IR, et al,. (2002). Signal regulatory protein (SIRPα), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem 277: 10028-10036.
83. Lundberg P, Koskinen C, Baldock PA, Löthgren H, Stenberg A, Lerner UH, et al,. (2007). Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPα-interaction. Biochem Biophys Res Commun 352: 444-448.
84. McDonald JF, Zheleznyak A, Frazier WA, (2004). Cholesterol-independent interactions with CD47 enhance αvβ3 avidity. J Biol Chem 279: 17301-17311.
85. Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD Jr, et al,. (2009). CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukaemia stem cells. Cell 138: 286-299.
86. Manna PP, Frazier WA, (2003). The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A. J Immunol 170: 3544-3553.
87. Manna PP, Frazier WA, (2004). CD47 mediates killing of breast tumour cells via Gi-dependent inhibition of protein kinase A. Cancer Res 64: 1026-1036.
88. Manna PP, Dimitry J, Oldenborg PA, Frazier WA, (2005). CD47 augments Fas/CD95-mediated apoptosis. J Biol Chem 280: 29637-29644.
89. Mantovani A, Marchesi F, Portal C, Allavena P, Sica A, (2008). Linking inflammation reactions to cancer: novel targets for therapeutic strategies. Adv Exp Med Biol 610: 112-127.
90. Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G, et al,. (1999). CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat Med 5: 1277-1284.
91. Mateo V, Brown EJ, Biron G, Rubio M, Fisher A, Deist FL, et al,. (2002). Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood 100: 2882-2890.
92. Mawby WJ, Holmes CH, Anstee DJ, Spring FA, Tanner MJ, (1994). Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3. Biochem J 304: 525-530.
93. Maxhimer JB, Soto-Pantoja DR, Ridnour LA, Shih HB, Degraff WG, Tsokos M, et al,. (2009a). Radioprotection in normal tissue and delayed tumour growth by blockade of CD47 signalling. Sci Transl Med 1: 3ra7.
94. Maxhimer JB, Shih HB, Isenberg JS, Miller TW, Roberts DD, (2009b). Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective. Plast Reconstr Surg 124: 1880-1889.
95. Miller TW, Isenberg JS, Shih HB, Wang Y, Roberts DD, (2010a). Amyloid-β inhibits NO-cGMP signalling in a CD36- and CD47-dependent manner. PLoS ONE 5: e15686.
96. Miller TW, Isenberg JS, Roberts DD, (2010b). Thrombospondin-1 is an inhibitor of pharmacological activation of soluble guanylate cyclase. Br J Pharmacol 159: 1542-1547.
97. Miyashita M, Ohnishi H, Okazawa H, Tomonaga H, Hayashi A, Fujimoto TT, et al,. (2004). Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42. Mol Biol Cell 15: 3950-3963.
98. Murata T, Ohnishi H, Okazawa H, Murata Y, Kusakari S, Hayashi Y, et al,. (2006). CD47 promotes neuronal development through Src- and FRG/Vav2-mediated activation of Rac and Cdc42. J Neurosci 26: 12397-12407.
99. N'Diaye EN, Brown EJ, (2003). The ubiquitin-related protein PLIC-1 regulates heterotrimeric G protein function through association with GβI. J Cell Biol 163: 1157-1165.
100. Ogura T, Noguchi T, Murai-Takebe R, Hosooka T, Honma N, Kasuga M, (2004). Resistance of B16 melanoma cells to CD47-induced regulation of motility as a result of aberrant N-glycosylation of SHPS-1. J Biol Chem 279: 13711-13720.
101. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP, (2000). Role of CD47 as a marker of self on red blood cells. Science 288: 2051-2054.
102. Olsson M, Bruhns P, Frazier WA, Ravetch JV, Oldenborg PA, (2005). Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood 105: 3577-3582.
103. Parkos CA, Colgan SP, Liang TW, Nusrat A, Bacarra AE, Carnes DK, et al,. (1996). CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J Cell Biol 132: 437-450.
104. Parthasarathy R, Subramanian S, Boder ET, Discher DE, (2006). Post-translational regulation of expression and conformation of an immunoglobulin domain in yeast surface display. Biotechnol Bioeng 93: 159-168.
105. Petersen TR, Dickgreber N, Hermans IF, (2010). Tumour antigen presentation by dendritic cells. Crit Rev Immunol 30: 345-386.
106. Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP, (1999). CD47 signals T cell death. J Immunol 162: 7031-7040.
107. Piccio L, Vermi W, Boles KS, Fuchs A, Strader CA, Facchetti F, et al,. (2005). Adhesion of human T cells to antigen-presenting cells through SIRPβ2-CD47 interaction costimulates T-cell proliferation. Blood 105: 2421-2427.
108. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, et al,. (2011). Fusion between intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 71: 1497-1505.
109. Rabinovich GA, Gabrilovich D, Sotomayor EM, (2007). Immunosuppressive strategies that are mediated by tumour cells. Annu Rev Immunol 25: 267-296.
110. Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, et al,. (1998). Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16: 299-312.
111. Ramanathan S, Mazzalupo S, Boitano S, Montfort WR, (2011). Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration. Biochemistry 50: 7787-7799.
112. Rath GM, Schneider C, Dedieu S, Sartelet H, Morjani H, Martiny L, et al,. (2006a). Thrombospondin-1 C-terminal-derived peptide protects thyroid cells from ceramide-induced apoptosis through the adenylyl cyclase pathway. Int J Biochem Cell Biol 38: 2219-2228.
113. Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, et al,. (2006b). The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochim Biophys Acta 1763: 1125-1134.
114. Rebres RA, Vaz LE, Green JM, Brown EJ, (2001). Normal ligand binding and signalling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane-spanning domains. J Biol Chem 276: 34607-34616.
115. Rebres RA, Kajihara K, Brown EJ, (2005). Novel CD47-dependent intercellular adhesion modulates cell migration. J Cell Physiol 205: 182-193.
116. Reinhold MI, Lindberg FP, Plas D, Reynolds S, Peters MG, Brown EJ, (1995). In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci 108: 3419-3425.
117. Roué G, Bitton N, Yuste VJ, Montange T, Rubio M, Dessauge F, et al,. (2003). Mitochondrial dysfunction in CD47-mediated caspase-independent cell death: ROS production in the absence of cytochrome C and AIF release. Biochimie 85: 741-746.
118. Sagawa M, Shimizu T, Fukushima N, Kinoshita Y, Ohizumi I, Uno S, et al,. (2011). A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway. Cancer Sci 102: 1208-1215.
119. Sano S, Ohnishi H, Omori A, Hasegawa J, Kubota M, (1997). BIT, an immune antigen receptor-like molecule in the brain. FEBS Lett 411: 327-334.
120. Saumet A, Slimane MB, Lanotte M, Lawler J, Dubernard V, (2005). Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/αvβ3 in promyelocytic leukemia NB4 cells. Blood 106: 658-667.
121. Schwartz MA, Brown EJ, Fazeli B, (1993). A 50-kDa integrin-associated protein is required for integrin-regulated calcium entry in endothelial cells. J Biol Chem 268: 19931-19934.
122. Seiffert M, Brossart P, Cant C, Cella M, Colonna M, Brugger W, et al,. (2001). Signal-regulatory protein alpha (SIRPa) but not SIRPb is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood 97: 2741-2749.
123. 2+-dependent mechanism requiring CD47 and the integrin αvβ3. J Biol Chem 275: 4796-4802.
124. Shinohara M, Ohyama N, Murata Y, Okazawa H, Ohnishi H, Ishikawa O, et al,. (2006). CD47 regulation of epithelial cell spreading and migration, and its signal transduction. Cancer Sci 97: 889-895.
125. Sick E, Niederhoffer N, Takeda K, Landry Y, Gies JP, (2009). Activation of CD47 receptors causes histamine secretion from mast cells. Cell Mol Life Sci 66: 1271-1282.
126. Sick E, Boukhari A, Deramaudt T, Rondé P, Bucher B, André P, et al,. (2011). Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an Akt-dependent pathway. Glia 59: 308-319.
127. Smadja DM, d'Audignier C, Bièche I, Evrard S, Mauge L, Dias JV, et al,. (2011). Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol 31: 551-559.
128. Stefanidakis M, Newton G, Lee WY, Parkos CA, Luscinskas FW, (2008). Endothelial CD47 interaction with SITPI-is required for human T-cell transendothelial migration under shear flow conditions in vitro. Blood 112: 1280-1289.
129. Sterling H, Saginario C, Vignery A, (1998). CD44 occupancy prevents macrophage multinucleation. J Cell Biol 143: 837-847.
130. Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L, et al,. (1999). Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155: 441-452.
131. Tlsty TD, Coussens LM, (2006). Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
132. Tsai RK, Discher DE, (2008). Inhibition of 'self' engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol 180: 989-1003.
133. Tsao PW, Mousa SA, (1995). Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains. J Biol Chem 270: 23747-23753.
134. Tulasne D, Judd BA, Johansen M, Asazuma N, Best D, Brown EJ, et al,. (2001). C-terminal peptide of thrombospondin-1 induces platelet aggregation through the Fc receptor I-chain-associated signaling pathway and by agglutination. Blood 98: 3346-3352.
135. Uluçkan O, Becker SN, Deng H, Zou W, Prior JL, Piwnica-Worms D, et al,. (2009). CD47 regulates bone mass and tumour metastasis to bone. Cancer Res 69: 3196-3204.
136. Uno S, Kinoshita Y, Azuma Y, Tsunenari T, Yoshimura Y, Iida S, et al,. (2007). Antitumour activity of a monoclonal antibody against CD47 in xenograft models of human leukemia. Oncol Rep 17: 1189-1194.
137. Vallbo C, Damber JE, (2005). Thrombospondins, metalloproteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model. Acta Oncol 44: 293-298.
138. Vernon-Wilson EF, Kee WJ, Willis AC, Barclay AN, Simmons DL, Brown MH, (2000). CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPα 1. Eur J Immunol 30: 2130-2137.
139. Waclavicek M, Majdic O, Stulnig T, Berger M, Baumruker T, Knapp W, et al,. (1997). T cell stimulation via CD47: agonistic and antagonistic effects of monoclonal antibody 1/1A4. J Immunol 159: 5345-5354.
140. Wang XQ, Frazier WA, (1998). The thrombospondin receptor CD47 (IAP) modulates and associates with α2β1 integrin in vascular smooth muscle cells. Mol Biol Cell 9: 865-974.
141. Wang XQ, Lindberg FP, Frazier WA, (1999). Integrin-associated protein stimulates α2β1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases. J Cell Biol 147: 389-400.
142. Wilson KE, Li Z, Kara M, Gardner KL, Roberts DD, (1999). β1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signalling by thrombospondin-1 and thrombospondin-1 peptides. J Immunol 163: 3621-3628.
143. Wu AL, Wang J, Zheleznyak A, Brown EJ, (1999). Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol Cell 4: 619-625.
144. Xing C, Lee S, Kim WJ, Wang H, Yang YG, Ning M, et al,. (2009). Neurovascular effects of CD47 signalling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro. J Neurosci Res 87: 2571-2577.
145. Yagi M, Miyamoto T, Toyama Y, Suda T, (2006). Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells. J Bone Miner Metab 24: 355-358.
146. Yao M, Roberts DD, Isenberg JS, (2011). Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Pharmacol Res 63: 13-22.
147. Yoshida H, Tomiyama Y, Ishikawa J, Oritani K, Matsumura I, Shiraga M, et al,. (2000). Integrin-associated protein/CD47 regulates motile activity in human B-cell lines through CDC42. Blood 96: 234-241.